Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00823459
Title Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.